The Safety and Efficacy of Thrombolysis for Strokes After Cardiac Catheterization

Journal of the American College of Cardiology

Volumn 51, Issue 9, 2008, Pages 906-911

  Khatri, Pooja ^a   Taylor, Robert A ^b   Palumbo, Vanessa ^c   Rajajee, Venkatakrishna ^d   Katz, Jeffrey M ^e   Chalela, Julio A ^f   Geers, Ann ^a   Haymore, Joseph ^g   Kolansky, Daniel M ^h   Kasner, Scott E ⁱ  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Sundaram Medical Foundation   (India)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HEART CATHETERIZATION; HEMODYNAMICS; HEMOPERICARDIUM; HUMAN; MORBIDITY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HEART CATHETERIZATION; HUMANS; MALE; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 39549099707     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.09.068     Document Type: Article

References (28)

1. Khatri P., and Kasner S.E. Ischemic strokes after cardiac catheterization: opportune thrombolysis candidates?. Arch Neurol 63 (2006) 817-821
2. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
3. Demaerschalk B.M., and Yip T.R. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke 36 (2005) 2500-2503
4. Kleindorfer D., Kissela B., Schneider A., et al., Neuroscience Institute. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 35 (2004) e27-e29
5. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 (1999) 2003-2011
6. Smith W.S., Sung G., Starkman S., et al., MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005) 1432-1438
7. Sankaranarayanan R., Msairi A., and Davis G.K. Stroke complicating cardiac catheterization-a preventable and treatable complication. J Invasive Cardiol 19 (2007) 40-45
8. Serry R., Tsimikas S., Imbesi S.G., and Mahmud E. Treatment of ischemic stroke complicating cardiac catheterization with systemic thrombolytic therapy. Catheter Cardiovasc Interv 66 (2005) 364-368
9. Kasner S.E., Cucchiara B.L., McGarvey M.L., Luciano J.M., Liebeskind D.S., and Chalela J.A. Modified National Institutes of Health Stroke Scale can be estimated from medical records. Stroke 34 (2003) 568-570
10. Kleindorfer D.O., Khatri P., and Katzan I. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 65 (2005) 1844 author reply 1844
11. Johnston K.C., Connors Jr. A.F., Wagner D.P., and Haley Jr. E.C. Predicting outcome in ischemic stroke: external validation of predictive risk models. Stroke 34 (2003) 200-202
12. Kissela B.M., Kothari R.U., Tomsick T.A., Woo D., and Broderick J.P. Embolization of calcific thrombi after tissue plasminogen activator treatment. J Stroke Cerebrovasc Dis 10 (2001) 135-138
13. Hinkle D.A., Raizen D.M., McGarvey M.L., and Liu G.T. Cerebral air embolism complicating cardiac ablation procedures. Neurology 56 (2001) 792-794
14. Wijman C.A., Kase C.S., Jacobs A.K., and Whitehead R.E. Cerebral air embolism as a cause of stroke during cardiac catheterization. Neurology 51 (1998) 318-319
15. Molina C.A., Montaner J., Arenillas J.F., Ribo M., Rubiera M., and Alvarez-Sabin J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 35 (2004) 486-490
16. Chan A.W., and Henderson M.A. Immediate catheter-directed reperfusion for acute stroke occurring during diagnostic cardiac catheterization. Catheter Cardiovasc Interv 67 (2006) 314-318
17. Horowitz M., Jovin T., Levy E., and Anderson W. Emergent basilar artery and bilateral posterior cerebral artery angioplasty, urokinase thrombolysis, and stenting for acute basilar artery occlusion secondary to diagnostic cardiac catheterization: case presentation. J Neuroimaging 15 (2005) 315-318
18. Presbitero P., Gasparini G.L., and Pagnotta P. Images in cardiovascular medicine. Intra-arterial thrombolysis for left middle cerebral artery embolic stroke during coronary angiography. Circulation 113 (2006) e64-e66
19. Zaidat O.O., Slivka A.P., Mohammad Y., et al. Intra-arterial thrombolytic therapy in peri-coronary angiography ischemic stroke. Stroke 36 (2005) 1089-1090
20. Kleindorfer D, Lindsell C, Brass L, Koroshetz W, Broderick JP. National US estimates of rt-PA use: ICD-9 codes substantially underestimate. Stroke 2008. In press.
21. Hacke W., Donnan G., Fieschi C., et al., ATLANTIS Trial Investigators, ECASS Trial Investigators, NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
22. Broderick J.P., Lu M., Kothari R., et al. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke 31 (2000) 2335-2341
23. Bruno A., Saha C., and Williams L.S. Using change in the National Institutes of Health Stroke Scale to measure treatment effect in acute stroke trials. Stroke 37 (2006) 920-921
24. Kasner S.E. Clinical interpretation and use of stroke scales. Lancet Neurol 5 (2006) 603-612
25. Khatri P., Wechsler L.R., and Broderick J.P. ICH associated with revascularization therapies. Stroke 38 (2007) 431-440
26. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35 (2004) 904-911
27. Chalela J.A., Katzan I., Liebeskind D.S., et al. Safety of intra-arterial thrombolysis in the postoperative period. Stroke 32 (2001) 1365-1369
28. Katzan I.L., Masaryk T.J., Furlan A.J., et al. Intra-arterial thrombolysis for perioperative stroke after open heart surgery. Neurology 52 (1999) 1081-1084